Suchergebnisse - "Park, Sung-Soo"

PubPharm (11)

1

Real-world outcome of patients with extensively pretreated multiple myeloma who were treated with selinexor and dexamethasone : a Korean multicenter retrospective analysis

enthalten in: Annals of hematology | 2024

von Yi, J. | Park, S. | Min, C. | +10

2

Real-world treatment outcomes of carfilzomib plus dexamethasone in patients with relapsed and/or refractory multiple myeloma, focusing on the impact of trial-fitness : CAtholic REsearch network for Multiple Myeloma study (CAREMM-2203)

enthalten in: Journal of cancer research and clinical oncology | 2023

von Park, S. | Goo, S. | Jeon, Y. | +3

3

Advantage of achieving deep response following frontline daratumumab-VTd compared to VRd in transplant-eligible multiple myeloma : multicenter study

enthalten in: Blood research | 2023

von Byun, J. | Park, S. | Yoon, S. | +8

4

Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantation

enthalten in: Journal for immunotherapy of cancer | 2019

von Lee, S. | Lim, J. | Kim, T. | +13

5

Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantation

enthalten in: Journal for ImmunoTherapy of Cancer | 2019

von Lee, S. | Lim, J. | Kim, T. | +13

6

Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantation

enthalten in: Journal for ImmunoTherapy of Cancer | 2019

von Lee, S. | Lim, J. | Kim, T. | +13

7

Low frequency of CD3+CD4+CD161+ T cells correlates with the occurrence of infections in refractory/relapsed multiple myeloma patients receiving lenalidomide plus low-dose dexamethasone treatment

enthalten in: Annals of hematology | 2018

von Lee, S. | Lim, J. | Ryu, D. | +13

8

Low frequency of $ CD3^{+} $$ CD4^{+} $$ CD161^{+} $ T cells correlates with the occurrence of infections in refractory/relapsed multiple myeloma patients receiving lenalidomide plus low-dose dexamethasone treatment

enthalten in: Annals of hematology | 2018

von Lee, S. | Lim, J. | Ryu, D. | +13

9

Low frequency of $ CD3^{+} $$ CD4^{+} $$ CD161^{+} $ T cells correlates with the occurrence of infections in refractory/relapsed multiple myeloma patients receiving lenalidomide plus low-dose dexamethasone treatment

enthalten in: Annals of hematology | 2018

von Lee, S. | Lim, J. | Ryu, D. | +13

10

Low frequency of $ CD3^{+} %$ CD4^{+} %$ CD161^{+} $ T cells correlates with the occurrence of infections in refractory/relapsed multiple myeloma patients receiving lenalidomide plus low-dose dexamethasone treatment

enthalten in: Annals of hematology | 2018

von Lee, S. | Lim, J. | Ryu, D. | +13